Amn Healthcare Services
AMN · Health Care Services
$48.01
2.5%Concentra Group Holdings Parent
CON · Health Care Services
$39.25
1.8%The short version
- Amn Healthcare Services is the larger business, with $2.7B of revenue in fiscal 2025 against $2.2B for Concentra Group Holdings Parent.
- Concentra Group Holdings Parent grew revenue faster (13.9%, against −8.5%).
- Concentra Group Holdings Parent kept more of each dollar of sales as operating profit (15.4% operating margin, against −2.0% operating margin).
- Concentra Group Holdings Parent turned more of its sales into free cash flow (9.1% FCF margin, against 8.6% FCF margin).
- Concentra Group Holdings Parent earned a higher return on the capital invested in it (14.9%, against −2.8%).
- Investors pay more for each dollar of Concentra Group Holdings Parent’s earnings: a P/E of 25.3x against 17.9x for Amn Healthcare Services.
| Latest fiscal year | AMN · FY25 | CON · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.9B | $5.0B |
| Revenue | $2.7B | $2.2B |
| Free cash flow | $234M | $197M |
| Net income | −$95.7M | $166M |
| Growth | ||
| Revenue growth | −8.5% | 13.9% |
| 5-year growth | 2.7% | — |
| Share count change | 0.9% | 12.3% |
| Profitability | ||
| Gross margin | 28.4% | — |
| Operating margin | −2.0% | 15.4% |
| Net margin | −3.5% | 7.7% |
| FCF margin | 8.6% | 9.1% |
| Return on capital | −2.8% | 14.9% |
| Return on equity | −14.2% | 49.8% |
| Balance sheet | ||
| Net debt | $733M | $1.5B |
| Net debt / EBITDA | 7.3x | 3.7x |
| Dividends and buybacks | $0.0M | $54.5M |
| Valuation & quality | ||
| P/E | 17.9x | 25.3x |
| Piotroski F-score | 5 | 5 |
FY16
AMN $1.9B
CON —
FY17
AMN $2.0B
CON —
FY18
AMN $2.1B
CON —
FY19
AMN $2.2B
CON —
FY20
AMN $2.4B
CON —
FY21
AMN $4.0B
CON —
FY22
AMN $5.2B
CON $1.7B
FY23
AMN $3.8B
CON $1.8B
FY24
AMN $3.0B
CON $1.9B
FY25
AMN $2.7B
CON $2.2B
AMN
CON
FY16
AMN 10.1%
CON —
FY17
AMN 10.7%
CON —
FY18
AMN 9.5%
CON —
FY19
AMN 8.0%
CON —
FY20
AMN 6.2%
CON —
FY21
AMN 12.0%
CON —
FY22
AMN 12.3%
CON 15.0%
FY23
AMN 8.9%
CON 15.7%
FY24
AMN −3.4%
CON 16.0%
FY25
AMN −2.0%
CON 15.4%
AMN
CON
FY16
AMN $112M
CON —
FY17
AMN $134M
CON —
FY18
AMN $192M
CON —
FY19
AMN $190M
CON —
FY20
AMN $219M
CON —
FY21
AMN $252M
CON —
FY22
AMN $578M
CON $228M
FY23
AMN $268M
CON $169M
FY24
AMN $240M
CON $210M
FY25
AMN $234M
CON $197M
AMN
CON
FY16
AMN 17.5%
CON —
FY17
AMN 17.6%
CON —
FY18
AMN 15.9%
CON —
FY19
AMN 11.6%
CON —
FY20
AMN 7.9%
CON —
FY21
AMN 20.3%
CON —
FY22
AMN 26.0%
CON —
FY23
AMN 12.8%
CON —
FY24
AMN −4.2%
CON —
FY25
AMN −2.8%
CON 14.9%
AMN
CON
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.